Filter
59
Text search:
U.S.
Food
and
Drug
Administration
Featured
2
11
Language
Document type
33
13
7
3
2
1
Countries / Regions
2
2
2
2
2
2
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
15
4
3
2
2
1
1
Toolboxes
8
5
5
4
3
3
3
3
3
2
2
1
1
1
1
To help trainers to create awareness,attitude and skills in waste handlers in day to day management of medical waste in health care settings.
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to prov
...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate
...
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newbor
...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan
...
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influe
...
Every five minutes a child dies as the result of violence, according to a ground-breaking report from Unicef UK. The report reveals that the vast majority of children are killed outside warzones and that physical, sexual
...
Third Edition
Best Practices in health care waste management
recommended
Examples from four Philippine Hospitals
Innocenti Digest No. 13
PLoS Negl Trop Dis 10(7): e0004794. doi:10.1371/journal.pntd.0004794
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte
...
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
